{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Acadia Healthcare Co., Inc.
Acadia Healthcare Adjusts Valuation Amid Mixed Technical Indicators and Profit Challenges
Acadia Healthcare Co., Inc. has recently experienced a change in its valuation grade, now reflecting a fair classification. Key financial metrics indicate a more balanced valuation compared to industry peers, although the company continues to face challenges, including declining net profit and a high debt-equity ratio.
Acadia Healthcare Adjusts Valuation Amid Declining Profits and Rising Debt Concerns
Acadia Healthcare Co., Inc. has recently experienced a score adjustment reflecting a fair valuation classification. This change is influenced by various financial metrics, including a P/E ratio of 8 and a price to book value of 0.69, amidst challenges such as a significant net profit decline and a high debt-equity ratio.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of November 21, 2025, Acadia Healthcare Co., Inc. is considered undervalued with a P/E ratio of 8, an EV to EBITDA ratio of 6.69, and a Price to Book Value of 0.69, especially when compared to peers like Encompass Health Corp. and The Ensign Group, despite a poor year-to-date return of -61.72%.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of November 7, 2025, Acadia Healthcare Co., Inc. is considered overvalued with a valuation grade of expensive, reflected by a low P/E ratio of 8 compared to peers and a poor year-to-date return of -54.17%.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of November 7, 2025, Acadia Healthcare Co., Inc. is considered overvalued with a P/E ratio of 8, significantly lower than its peers, and has experienced a poor year-to-date return of -50.79%, contrasting sharply with the S&P 500's positive return of 14.40%.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of November 7, 2025, Acadia Healthcare Co., Inc. is considered overvalued with a P/E ratio of 8 and an EV to EBITDA ratio of 6.69, significantly lower than its peers, while also underperforming the S&P 500 with a year-to-date return of -50.79%.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 31, 2025, Acadia Healthcare Co., Inc. is fairly valued with a P/E ratio of 8, but has underperformed the S&P 500 with a year-to-date return of -47.89%.
Acadia Healthcare Co., Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges
Acadia Healthcare Co., Inc. has recently adjusted its valuation, with its stock price at $21.31. Over the past year, the company has experienced significant challenges, reflected in a -49.29% return. Key financial metrics indicate a conservative market position compared to peers in the Pharmaceuticals & Biotechnology sector.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 31, 2025, Acadia Healthcare Co., Inc. is considered fairly valued and potentially undervalued with a P/E ratio of 8, a Price to Book Value of 0.69, and an EV to EBITDA of 6.69, especially when compared to peers like Encompass Health Corp. and The Ensign Group, despite underperforming the S&P 500 with a year-to-date return of -45.78%.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 31, 2025, Acadia Healthcare Co., Inc. is considered fairly valued and potentially undervalued with a P/E ratio of 8, significantly lower than its peers, despite a year-to-date stock performance of -45.78% compared to the S&P 500's 16.30% return.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 17, 2025, Acadia Healthcare Co., Inc. is fairly valued with a low P/E ratio of 8, indicating potential undervaluation compared to peers, but has experienced poor stock performance with a year-to-date return of -39.05% and a three-year return of -70.67%.
Acadia Healthcare Co., Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
Acadia Healthcare Co., Inc. has recently adjusted its valuation, showcasing a P/E ratio of 8 and a price-to-book value of 0.69. The company has experienced significant stock volatility, with a year-to-date return of -39.05% and a 59.26% decline over the past year, highlighting ongoing market challenges.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 17, 2025, Acadia Healthcare Co., Inc. is considered fairly valued despite its attractive metrics, such as a P/E ratio of 8, indicating potential undervaluation compared to peers, while its year-to-date stock performance has significantly underperformed the S&P 500.
Is Acadia Healthcare Co., Inc. overvalued or undervalued?
As of October 17, 2025, Acadia Healthcare Co., Inc. is fairly valued with attractive metrics indicating it may be undervalued compared to peers, but its poor stock performance, with a year-to-date return of -39.05%, raises concerns for investors.
Acadia Healthcare Co., Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Acadia Healthcare Co., Inc. has experienced recent stock fluctuations, with a current price of $26.46. Technical indicators show mixed trends, with some suggesting bullish and others bearish signals. While Acadia has outperformed the S&P 500 in the short term, its year-to-date performance reflects significant challenges.
Is Acadia Healthcare Co., Inc. technically bullish or bearish?
As of October 3, 2025, Acadia Healthcare's trend is neutral with mixed signals; it has outperformed the S&P 500 recently but underperformed year-to-date, showing a mildly bullish weekly MACD and a bearish monthly MACD.
Is Acadia Healthcare Co., Inc. technically bullish or bearish?
As of October 3, 2025, Acadia Healthcare's technical trend is neutral with mixed signals, showing short-term outperformance against the S&P 500 but a significant year-to-date underperformance.
Is Acadia Healthcare Co., Inc. technically bullish or bearish?
As of October 3, 2025, Acadia Healthcare's technical trend is neutral with mixed signals, showing short-term outperformance against the S&P 500 but a significant year-to-date underperformance.
Acadia Healthcare Hits Day High with 11.67% Surge in Stock Price
Acadia Healthcare Co., Inc. saw a notable increase in stock performance on September 24, 2025, reaching an intraday high. While recent gains contrast with a significant one-year decline, the company has faced ongoing financial challenges, including negative quarterly results and a high debt-equity ratio, indicating potential strain.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
